Latest News
Cannabidiol and Cannabigerol Effectively Inhibit CCA Cells
Newly Identified Hub Genes as Methylation-Based Biomarkers in CCA
ATG7 Variants Affect Autophagy Function in Cholangiocarcinoma
Drug-Eluting Beads With Systemic Therapy Shows Promise for CCA
Biliary Surgery, SMAD4, and PBRM1 Predict Metastasis Risk in CCA
Researchers Support Caudate Resection in Managing Perihilar CCA
Mean Platelet Volume as a New Marker to Distinguish iCCA From HCC
New Model Uses N6-Methyladenosine to Predict CCA Prognosis
Preoperative Inflammatory Markers Show Prognostic Value in CCA
Latest Clinical Trials
Insights
The Practicalities of Genomic Profiling for Cholangiocarcinoma
Genomic profiling for cholangiocarcinoma and other cancers demonstrates significant evidence-based benefits, but faces practical hurdles.
Recent Changes in the Diagnosis and Treatment of Perihilar Cholangiocarcinoma
Over the last decade, medical research has led to significant progress in the diagnosis and treatment of perihilar cholangiocarcinoma.
Predicting the Prognosis of Patients With Intrahepatic Cholangiocarcinoma
Disease progression has a major impact on outcomes in patients with intrahepatic cholangiocarcinoma and many factors influence recurrence-free survival, studies have found.
The Expanding Role of Radiomics in Cholangiocarcinoma and Beyond
Many are heralding radiomics as the “next big thing” that will revolutionize medicine. We examine this claim, particularly when it comes to cholangiocarcinoma treatment.
Diagnosing Intrahepatic Cholangiocarcinoma Carries Specific Challenges
Researchers explain the specific challenges of diagnosing and managing iCCA, and why a multidisciplinary approach works best.
Understanding the Risk Factors of the Subtypes of Cholangiocarcinoma
We explore the risk factors associated with the various subtypes of cholangiocarcinoma and discuss their reliability.
The Role of Medical Imaging in Diagnosing and Monitoring Cholangiocarcinoma
Various medical imaging tools can play key roles in the detection, diagnosis, and monitoring of cholangiocarcinoma.
Cholangiocarcinoma Features
Cholangiocarcinoma Experts Find Hope in Newly Approved and Emerging Therapies
Dr. Reham Abdel-Wahab of the Cholangiocarcinoma Foundation says a raft of FDA-approved therapies and ongoing clinical trials will expand treatment options.
Using Technology to Boost Ethnic, Geographic Diversity in Clinical Trials
Eliminating geographic and ethnic bias in clinical trials for rare diseases is the goal of Jeeva Informatics, says founder and CEO Harsha K. Rajasimha, PhD.
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Cholangiocarcinoma Foundation Helps Improve Odds for Patients With Rare Bile Duct Cancer
Melinda Bachini, 52, never intended to be a patient advocate for a disease few people have ever heard of, let alone pronounce. But a 2009 diagnosis of cholangiocarcinoma changed everything for the mother of 6.
Rare Care Podcast
- Loading...
Loading...
Loading... 
Loading...